Related Experiment Video
Updated: Jun 27, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Revisiting Libman-Sacks endocarditis: a historical review and update
Jennifer L Lee1, Stanley M Naguwa, Gurtej S Cheema
1Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA 95616, USA.
Libman-Sacks endocarditis involves sterile heart valve lesions, often linked to autoimmune diseases like lupus and antiphospholipid syndrome. While usually mild, it can cause serious complications requiring medical intervention.
Area of Science:
- Cardiology
- Rheumatology
- Pathology
Background:
- Libman-Sacks (LS) endocarditis, described in 1924, presents as sterile, verrucous valvular lesions.
- It is recognized as a cardiac manifestation of systemic lupus erythematosus and antiphospholipid syndrome (APS).
Purpose of the Study:
- To review the characteristics, complications, and associations of Libman-Sacks endocarditis.
- To highlight the role of evolving imaging techniques in disease assessment.
Main Methods:
- Literature review and analysis of historical and recent clinical data.
- Examination of diagnostic advancements, particularly in echocardiography.
Main Results:
- LS endocarditis typically affects mitral and aortic valves.
- Complications include valvular insufficiency, infective endocarditis, and thromboembolic events (stroke, TIA).
- Echocardiography aids in prevalence estimation, though further research is needed.
Conclusions:
- LS endocarditis is a significant cardiac manifestation of APS and SLE.
- Further research into pathogenesis, treatment, and APS association is warranted.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis I: Introduction
Endocarditis IV: Nursing Management
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis III: Medical Management
Mitral Stenosis III: Medical Management